Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mercedes Santoro

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Diagnostic Microbiology and Infectious Disease|December 5, 2021
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countriesJoseph Fokam, Ezechiel Ngoufack Jagni Semengue, Daniele Armenia, et al.
AIDS Research and Therapy|November 21, 2019
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat"Joseph Fokam, Samuel Martin Sosso, Bouba Yagai, et al.
Viruses|July 29, 2023
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line RegimensJoseph Fokam, Collins Ambe Chenwi, Valère Tala, et al.
Viruses|January 8, 2025
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income CountriesDavy-Hyacinthe Gouissi Anguechia, Yagai Bouba, Ezechiel Ngoufack Jagni Semengue, et al.
Therapeutic Advances in Infectious Disease|April 28, 2025
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocolVincent Kamaël Mekel, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka'e, et al.
Viruses|September 28, 2024
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 StudyFrancesca Bai, Andrea Santoro, Pontus Hedberg, et al.
HIV Medicine|December 24, 2021
Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY studyJoseph Fokam, Marie Laure Mpouel Bala, Maria-Mercedes Santoro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2022
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean EuropeAdolfo de Salazar, Laura Viñuela, Ana Fuentes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levelsMaria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, et al.
Viruses|September 28, 2024
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in ItalyDaniele Armenia, Luca Carioti, Valeria Micheli, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Diagnostic Microbiology and Infectious Disease|December 5, 2021
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countriesJoseph Fokam, Ezechiel Ngoufack Jagni Semengue, Daniele Armenia, et al.
AIDS Research and Therapy|November 21, 2019
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat"Joseph Fokam, Samuel Martin Sosso, Bouba Yagai, et al.
Viruses|July 29, 2023
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line RegimensJoseph Fokam, Collins Ambe Chenwi, Valère Tala, et al.
Viruses|January 8, 2025
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income CountriesDavy-Hyacinthe Gouissi Anguechia, Yagai Bouba, Ezechiel Ngoufack Jagni Semengue, et al.
Therapeutic Advances in Infectious Disease|April 28, 2025
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocolVincent Kamaël Mekel, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka'e, et al.
Viruses|September 28, 2024
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 StudyFrancesca Bai, Andrea Santoro, Pontus Hedberg, et al.
HIV Medicine|December 24, 2021
Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY studyJoseph Fokam, Marie Laure Mpouel Bala, Maria-Mercedes Santoro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2022
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean EuropeAdolfo de Salazar, Laura Viñuela, Ana Fuentes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levelsMaria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, et al.
Viruses|September 28, 2024
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in ItalyDaniele Armenia, Luca Carioti, Valeria Micheli, et al.
Pageof 14